Literature DB >> 24376966

Application of IMRT in adjuvant treatment of soft tissue sarcomas of the thigh-Preliminary results.

Anna Sladowska1, Marcin Hetnał1, Paweł Dymek1, Damian Kabat1, Kamil Kisielewicz1, Michał Wawrzak1, Paweł Zawadzki1, Jan Lesiak1, Edward Byrski1, Michał Waligórski2.   

Abstract

BACKGROUND: Fracture of the femur is the most frequent late complication in patients with soft tissue sarcomas (STS) who receive external beam radiotherapy after limb-sparing surgery. AIM: To reduce the risk of bone fracture following radiotherapy of STS of the thigh, we minimized the dose to the femur and to surrounding normal tissues by applying intensity modulated radiation therapy (IMRT). We report preliminary results of post-surgery IMRT of the thigh in patients with STS in this extremity.
MATERIALS AND METHODS: 10 adult patients undergoing post-operative radiotherapy of STS of the thigh were treated using IMRT. Clinical IMRT plans with simultaneous integrated boost (SIB) and 3-phase three-dimensional conformal radiotherapy (3D-CRT) were designed to adequately treat the planning target volume and to spare the femur to the largest extent possible. Dose distributions and dose-volume histograms were compared.
RESULTS: For either technique, a comparable target coverage was achieved; however, target volume was better covered and critical structures were better spared in IMRT plans. Mean and maximum doses to OAR structures were also significantly reduced in the IMRT plans. On average, the mean dose to the femur in 3D-CRT plans was about two times higher than that in IMRT plans.
CONCLUSION: Compared with 3D-CRT, the application of IMRT improves the dose distribution within the concave target volumes and reduces dose to the OAR structures without compromising target coverage.

Entities:  

Keywords:  3D-CRT; IMRT; Soft tissue sarcoma

Year:  2011        PMID: 24376966      PMCID: PMC3863250          DOI: 10.1016/j.rpor.2011.02.006

Source DB:  PubMed          Journal:  Rep Pract Oncol Radiother        ISSN: 1507-1367


  14 in total

Review 1.  The physical basis of IMRT and inverse planning.

Authors:  S Webb
Journal:  Br J Radiol       Date:  2003-10       Impact factor: 3.039

Review 2.  Evidence-based recommendations for local therapy for soft tissue sarcomas.

Authors:  Peter W T Pisters; Brian O'Sullivan; Robert G Maki
Journal:  J Clin Oncol       Date:  2007-03-10       Impact factor: 44.544

3.  Fractures following radiotherapy and limb-salvage surgery for lower extremity soft-tissue sarcomas. A comparison of high-dose and low-dose radiotherapy.

Authors:  Ginger E Holt; Anthony M Griffin; Melania Pintilie; Jay S Wunder; Charles Catton; Brian O'Sullivan; Robert S Bell
Journal:  J Bone Joint Surg Am       Date:  2005-02       Impact factor: 5.284

4.  Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.

Authors:  Andrew Lauve; Monica Morris; Rupert Schmidt-Ullrich; Qiuwen Wu; Radhe Mohan; Olubumni Abayomi; David Buck; Diane Holdford; Kathryn Dawson; Laurence Dinardo; Evan Reiter
Journal:  Int J Radiat Oncol Biol Phys       Date:  2004-10-01       Impact factor: 7.038

Review 5.  Management of radiation-associated fractures.

Authors:  Christopher P Cannon; Patrick P Lin; Valerae O Lewis; Alan W Yasko
Journal:  J Am Acad Orthop Surg       Date:  2008-09       Impact factor: 3.020

6.  Intensity-modulated radiotherapy for soft tissue sarcoma of the thigh.

Authors:  Linda Hong; Kaled M Alektiar; Margie Hunt; Ennapadam Venkatraman; Steven A Leibel
Journal:  Int J Radiat Oncol Biol Phys       Date:  2004-07-01       Impact factor: 7.038

7.  Intensity modulated radiation therapy for primary soft tissue sarcoma of the extremity: preliminary results.

Authors:  Kaled M Alektiar; Linda Hong; Murray F Brennan; Cesar Della-Biancia; Samuel Singer
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-03-23       Impact factor: 7.038

8.  Tumor radioresponsiveness versus fractionation sensitivity.

Authors:  H D Thames; H D Suit
Journal:  Int J Radiat Oncol Biol Phys       Date:  1986-04       Impact factor: 7.038

9.  Pathologic femoral fracture after periosteal excision and radiation for the treatment of soft tissue sarcoma.

Authors:  P P Lin; K D Schupak; P J Boland; M F Brennan; J H Healey
Journal:  Cancer       Date:  1998-06-15       Impact factor: 6.860

10.  Intensity modulated radiation therapy for retroperitoneal sarcoma: a case for dose escalation and organ at risk toxicity reduction.

Authors:  Mary Koshy; Jerome C Landry; Joshua D Lawson; Charles A Staley; Natia Esiashvili; Rebecca Howell; Shahram Ghavidel; Lawrence W Davis
Journal:  Sarcoma       Date:  2003
View more
  7 in total

1.  The importance of accurate treatment planning, delivery, and dose verification.

Authors:  Julian Malicki
Journal:  Rep Pract Oncol Radiother       Date:  2012-03-06

2.  Beam rate influence on dose distribution and fluence map in IMRT dynamic technique.

Authors:  Krzysztof Slosarek; Aleksandra Grządziel; Wojciech Osewski; Lukasz Dolla; Barbara Bekman; Borislava Petrovic
Journal:  Rep Pract Oncol Radiother       Date:  2012-02-10

3.  The next generation of radiation oncologists: Challenges and perspectives.

Authors:  Arturo Navarro; J Cacicedo
Journal:  Rep Pract Oncol Radiother       Date:  2012-09-25

4.  Management of extremely hard-to-heal extremity wounds with severe life-threatening complications.

Authors:  Aijia Cai; Anja M Boos; Andreas Arkudas; Raymund E Horch
Journal:  Int Wound J       Date:  2016-10-25       Impact factor: 3.315

5.  Intensity modulated radiation therapy (IMRT) for the treatment of unicentric Castlemans disease: a case report and review of the use of radiotherapy in the literature.

Authors:  Chance Matthiesen; Rajeev Ramgopol; Jonathan Seavey; Salahuddin Ahmad; Terence Herman
Journal:  Radiol Oncol       Date:  2012-01-02       Impact factor: 2.991

6.  Application of Volumetric Modulated Arc Therapy and Simultaneous Integrated Boost Techniques to Prepare "Safe Margin" in the Rabbit VX2 Limb Tumor Model.

Authors:  Chong-Wen Wang; Yang Zhou; Jing-Ping Bai; Hao Liu; Yan Liu; Guang-Li Shi; Jiao-Jiao Ding; Dong-Hui Ma; Wen-Ting Li; Peng-Ming Xie; Yue Yan
Journal:  Med Sci Monit       Date:  2015-08-15

Review 7.  Managing sarcoma: where have we come from and where are we going?

Authors:  Jenna S Bleloch; Reyna D Ballim; Serah Kimani; Jeannette Parkes; Eugenio Panieri; Tarryn Willmer; Sharon Prince
Journal:  Ther Adv Med Oncol       Date:  2017-09-20       Impact factor: 8.168

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.